Through the 90-day period concluding February 19, 2026, Pyxis Oncology's top three insider stakeholders include TenPercentOwner Inc Pfizer (5.95Mn shares), Other World Investments B.V. Bayer (2.74Mn shares), President And Ceo Lara Sullivan (2.40Mn shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Inc Pfizer | 5,952,263 | 23 Mar, 2023 | |
| World Investments B.V. Bayer | 2,742,338 | 15 Oct, 2021 | |
| Lara Sullivan | President And Ceo | 2,403,882 | 18 Sep, 2023 |
| Pamela Ann Connealy | Cfo & Coo | 2,309,436 | 28 Mar, 2024 |
| Asset Management, Lp Cormorant | 1,118,854 | 15 Oct, 2021 | |
| Jay Feingold | Chief Medical Officer | 730,345 | 28 Mar, 2023 |
| John L Flavin | 413,015 | 28 Mar, 2024 | |
| Jitendra Wadhane | Svp And Chief Accounting Officer | 398,421 | 28 Mar, 2024 |
| Darren S Cline | 251,405 | 28 Mar, 2024 | |
| Freda C Lewis-Hall | 241,405 | 28 Mar, 2024 | |
| Thomas Civik | 221,886 | 28 Mar, 2023 | |
| Rachel Humphrey | 96,805 | 28 Mar, 2024 | |
| Mark Chin | 66,831 | 04 Apr, 2022 | |
| Jakob Dupont | 38,741 | 28 Mar, 2024 | |
| Santhosh Palani | 6,000 | 07 Jun, 2024 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 26 Nov, 2024 | Pamela Ann Connealy | Common Stock | A | 5,450 | $2.00 | 1,115,743 | I | P |
| 26 Nov, 2024 | Pamela Ann Connealy | Common Stock | A | 83,400 | $1.96 | 1,199,143 | I | P |
| 07 Jun, 2024 | Santhosh Palani | Common Stock | A | 6,000 | $0.00 | 6,000 | D | A |
| 07 Jun, 2024 | Santhosh Palani | - | - | 6,000 | D | |||
| 26 Mar, 2024 | John L Flavin | Common Stock | A | 35,219 | $0.00 | 413,015 | D | A |
| 26 Mar, 2024 | Freda C Lewis-Hall | Common Stock | A | 35,219 | $0.00 | 241,405 | D | A |
| 26 Mar, 2024 | Jakob Dupont | Common Stock | A | 38,741 | $0.00 | 38,741 | D | A |
| 26 Mar, 2024 | Rachel Humphrey | Common Stock | A | 38,741 | $0.00 | 96,805 | D | A |
| 26 Mar, 2024 | Darren S Cline | Common Stock | A | 35,219 | $0.00 | 251,405 | D | A |
| 26 Mar, 2024 | Pamela Ann Connealy | Common Stock | A | 328,710 | $0.00 | 1,110,293 | D | A |
| 26 Mar, 2024 | Pamela Ann Connealy | - | - | 1,110,293 | D | |||
| 26 Mar, 2024 | Jitendra Wadhane | Common Stock | A | 131,484 | $0.00 | 398,421 | D | A |
| 29 Nov, 2023 | Pamela Ann Connealy | Common Stock | D | 36,949 | $1.40 | 781,583 | D | F |
| 15 Nov, 2023 | Jitendra Wadhane | Common Stock | A | 40,000 | $0.00 | 266,937 | D | A |
| 28 Sep, 2023 | Pamela Ann Connealy | Common Stock | A | 8,000 | $1.87 | 818,532 | D | P |
| 27 Sep, 2023 | Pamela Ann Connealy | Common Stock | A | 6,426 | $1.85 | 810,532 | D | P |
| 27 Sep, 2023 | Jitendra Wadhane | Common Stock | A | 2,500 | $1.87 | 226,937 | D | P |
| 25 Sep, 2023 | Pamela Ann Connealy | Common Stock | A | 12,000 | $1.67 | 804,106 | D | P |
| 25 Sep, 2023 | Jitendra Wadhane | Common Stock | A | 5,000 | $1.77 | 224,437 | D | P |
| 22 Sep, 2023 | Pamela Ann Connealy | Common Stock | A | 5,000 | $1.74 | 792,106 | D | P |